Non-invasively estimate the risk of liver fibrosis in patients with chronic liver diseases using routine blood panel data.
The FIB-4 index is a validated, non-invasive scoring model used to gauge liver scarring without requiring a surgical biopsy. It is widely used to screen patients with non-alcoholic fatty liver disease (NAFLD/MASLD) or Hepatitis C for advanced fibrosis.
Input the patient’s age, platelet count, AST levels, and ALT levels. The tool runs the scoring algorithm and outputs a risk level, helping you determine if a gastroenterology or hepatology referral is necessary.
Yes, 100% Free! A great reference tool for primary care physicians, gastroenterologists, and health screening clinics.